Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer - Contacts and Locations

Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer

This study is ongoing, but not recruiting participants.

Study NCT00003264. Last updated on October 12, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00003264

Locations


United States, New Jersey
	Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County
	Mount Holly, New Jersey, United States, 08060
	Hunterdon Regional Cancer Center
	Flemington, New Jersey, United States, 08822
	Riverview Medical Center - Booker Cancer Center
	Red Bank, New Jersey, United States, 07701
	St. Francis Medical Center
	Trenton, New Jersey, United States, 08629

United States, Pennsylvania
	Delaware County Memorial Hospital
	Drexel Hill, Pennsylvania, United States, 19026
	Fox Chase Cancer Center
	Philadelphia, Pennsylvania, United States, 19111
	St. Luke's Network - Bethlehem
	Bethlehem, Pennsylvania, United States, 18015
	North Penn Hospital
	Lansdale, Pennsylvania, United States, 19446-1200
	Paoli Memorial Hospital
	Paoli, Pennsylvania, United States, 19301-1792
	Reading Hospital and Medical Center
	Reading, Pennsylvania, United States, 19612-6052
	Saint Mary Regional Center
	Langhorne, Pennsylvania, United States, 19047
	Harrisburg Polyclinic Medical Center
	Harrisburg, Pennsylvania, United States, 17101

Sponsors and Collaborators

Fox Chase Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Corey J. Langer, MD	Fox Chase Cancer Center